Yakira Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History

Yakira Capital Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,000	Closed	-$241K	–	208
2026 Q1	$241K	Buy	+6,000	New	+$129K	0.07%	137

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Yakira Capital Management's APLS Position: Q2 2026 in Review

Yakira Capital Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 6,000 shares — an estimated $241K sold.

Yakira Capital Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $241K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Yakira Capital Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Yakira Capital Management sold 6,000 Apellis Pharmaceuticals shares in Q2 2026, an estimated $241K.
Yakira Capital Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Yakira Capital Management's Apellis Pharmaceuticals position peaked at $241K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Yakira Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.